Fabio Iwamoto, Md

This study tested whether the immunotherapy drug nivolumab could help shrink recurrent brain tumors in adults who had previously received chemotherapy. The trial enrolled 35 adults with specific genetic mutations in their tumors that made them more likely to respond to immunother…